EcoDrugPlus

Neurogenic Locus Notch Homolog Protein 2-Like

Ensembl ID : ENSOKIG00005001745
Gene Symbol: LOC109898546
3 Cross references
196 Possible Orthologues:

Neuromedin-K Receptor

Ensembl ID : ENSOKIG00005028900
Gene Symbol: LOC109899890
3 Cross references
190 Possible Orthologues:

Neuromedin-K Receptor

Ensembl ID : ENSOKIG00005023944
Gene Symbol: LOC109900360
3 Cross references
242 Possible Orthologues:

Neuromedin-K Receptor-Like

Ensembl ID : ENSOKIG00005016023
Gene Symbol: LOC109894779
3 Cross references
242 Possible Orthologues:

Neuronal Acetylcholine Receptor Subunit Alpha-7

Ensembl ID : ENSOKIG00005036881
Gene Symbol: LOC109877812
2 Cross references
183 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSOKIG00005004299
Gene Symbol: NPY2R
3 Cross references
173 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSOKIG00005032772
Gene Symbol: NPY2R
3 Cross references
171 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSOKIG00005013110
Gene Symbol: NPY2R
3 Cross references
178 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSOKIG00005014912
Gene Symbol: NPY2R
1 Cross references
178 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSOKIG00005031620
Gene Symbol: NTSR1
1 Cross references
197 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSOKIG00005037138
Gene Symbol: NTSR1
3 Cross references
198 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSOKIG00005032295
Gene Symbol: NTRK2
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).